Home African Swine Fever [Inactivated vaccines] Development of cross protective/multivalent ASF inactivated/killed vaccine
African Swine Fever roadmap:
Vaccines

Roadmap for the development of a candidate vaccine for ASF

Download ASF Vaccine Roadmap

4

Inactivated vaccines

Dependencies

Next steps

Inactivated vaccines

Research Question

  • The development of an effective killed virus vaccine that provide protection and is safe

Research Gaps and Challenges

  • Having it efficacious
  • Cross protection
  • Stimulating protective response involving both VN Abs and CTC

Solution Routes

  • Selection of inactivated whole virus preparations
  • Monitoring the immune response following immunisation with the various candidates.
  • Challenge experiments with the various vaccine candidates

Dependencies

  • Selection of the right strain, titre and preparation/inactivation to induce a protective immunity
  • The availability of suitable adjuvants to stimulate strong CTC and VN-Ab responses

State Of the Art

  • Attempts to vaccinate animals using infected cell extracts, supernatants of infected pig peripheral blood leukocytes, purified and inactivated virions, infected glutaraldehyde-fixed macrophages, or detergent-treated infected alveolar macrophages failed to induce protective immunity

Projects

What activities are planned or underway?

Africa's Long Depression: The Growth and Debt Crises of 1975-2000

Planned Completion date 01/03/2027

Participating Country(s):

United KingdomIconUnited Kingdom